ScholarIQanswers from OpenAlex & ORCID
Yan Yu
ResearcherPublications, citations & collaboration network
Yan Yu is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Yan Yu have?
ScholarIQindexed works
Yan Yu has 155 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Yan Yu have?
ScholarIQcitation count
Yan Yu has 3,590 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Yan Yu?
ScholarIQh-index
Yan Yu has an h-index of 28 in OpenAlex.
What is the i10-index of Yan Yu?
ScholarIQi10-index
Yan Yu has an i10-index of 60 in OpenAlex.
What is the ORCID of Yan Yu?
ScholarIQorcid
The ORCID for Yan Yu is on the source record.
What is the OpenAlex record for Yan Yu?
ScholarIQopenalex
The OpenAlex for Yan Yu is on the source record.
What are the most-cited papers on Yan Yu?
ScholarIQmost cited works
Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC
David Planchard, Pasi A. Jänne, Ying Cheng, James Chih‐Hsin Yang, Noriko Yanagitani, Sang‐We Kim, Shunichi Sugawara, Yan Yu, Yun Fan, Sarayut Lucien Geater, К. К. Лактионов, Chee Khoon Lee, Natalia Valdiviezo, Samreen Ahmed, Jean-Marc Maurel, Igor Andrašina, Jonathan W. Goldman, Dana Ghiorghiu, Yuri Rukazenkov, Alex Todd, Kunihiko Kobayashi
Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2)
Lin Jiao, Hai‐Liang Zhang, Dandan Li, Ke-Li Yang, Jun Tang, Xuan Li, Jiao Ji, Yan Yu, Rui-Yan Wu, Ravichandran Senthilkumar, Jianjun Liu, Gong-Kan Feng, Min-Shan Chen, Yi-Xin Zeng, Rong Deng, Xiao‐Feng Zhu
Acetylation of Beclin 1 inhibits autophagosome maturation and promotes tumour growth
Ting Sun, Xuan Li, Peng Zhang, Wen-Dan Chen, Hai‐Liang Zhang, Dandan Li, Rong Deng, Xiao-Jun Qian, Lin Jiao, Jiao Ji, Yun-Tian Li, Rui-Yan Wu, Yan Yu, Gong-Kan Feng, Xiao‐Feng Zhu
CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression
Xuan Li, Kai‐Bin Yang, Wei Chen, Jia Mai, Xiao-Qi Wu, Ting Sun, Ruiyan Wu, Lin Jiao, Dandan Li, Jiao Ji, Hai‐Liang Zhang, Yan Yu, Yuhong Chen, Gong‐Kan Feng, Rong Deng, Jun‐Dong Li, Xiao‐Feng Zhu
Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)
Zhijie Wang, Lin Wu, Baolan Li, Ying Cheng, Xiaoling Li, Xicheng Wang, Liang Han, Xiaohong Wu, Yun Fan, Yan Yu, Dongqing Lv, Jianhua Shi, Jianjin Huang, Shaozhang Zhou, Baohui Han, Guogui Sun, Qisen Guo, Youxin Ji, Xiaoli Zhu, Sheng Hu, Wei Zhang, Qiming Wang, Yuming Jia, Ziping Wang, Yong Song, Jingxun Wu, Meiqi Shi, Xingya Li, Zhigang Han, Yunpeng Liu, Zhuang Yu, Anwen Liu, Xiuwen Wang, Caicun Zhou, Diansheng Zhong, Liyun Miao, Zhihong Zhang, Hui Zhao, Jiaqi Yang, Dong Wang, Yingyi Wang, Qiang Li, Xiaodong Zhang, Mei Ji, Zhenzhou Yang, Jiuwei Cui, Beili Gao, Buhai Wang, Hu Liu, Lei Nie, Mei He, Jin Shi, Wei Gu, Yongqian Shu, Tong Zhou, Jian Feng, Xinmei Yang, Cheng Huang, Bo Zhu, Yu Yao, Xiongwen Tang, Jianjun Yu, Ellen Maher, Hui Feng, Sheng Yao, Patricia Keegan, Jie Wang